Sun Ha Paek Selected Research

Neurocytoma

3/2013	Central neurocytoma: long-term outcomes of multimodal treatments and management strategies based on 30 years' experience in a single institute.
10/2008	Long-term outcome of conventional radiation therapy for central neurocytoma.
11/2007	Gamma knife radiosurgery for central neurocytoma: primary and secondary treatment.
8/2005	Immunohistochemical study of central neurocytoma, subependymoma, and subependymal giant cell astrocytoma.
2/2004	Forskolin promotes astroglial differentiation of human central neurocytoma cells.
2/2003	Linear accelerator radiosurgery for central neurocytoma: a case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sun Ha Paek Research Topics

Disease

47	Neoplasms (Cancer) 01/2022 - 12/2002
39	Parkinson Disease (Parkinson's Disease) 05/2022 - 04/2008
20	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 11/2002
10	Glioma (Gliomas) 01/2022 - 12/2009
9	Brain Neoplasms (Brain Tumor) 01/2021 - 05/2005
6	Neurocytoma 03/2013 - 02/2003
5	Dystonia (Limb Dystonia) 09/2019 - 01/2016
5	Meningioma (Meningiomas) 05/2019 - 12/2002
4	Dyskinesias (Dyskinesia) 01/2021 - 04/2008
4	Pain (Aches) 05/2015 - 12/2008
3	Disease Progression 05/2022 - 11/2013
3	Inflammation (Inflammations) 12/2020 - 06/2015
3	Parkinsonian Disorders (Parkinsonism) 01/2020 - 08/2012
3	Edema (Dropsy) 05/2019 - 12/2002
3	Adenoma (Adenomas) 02/2019 - 01/2012
3	Hyperthermia 02/2018 - 08/2013
3	Neoplasm Metastasis (Metastasis) 11/2015 - 01/2003
3	Tremor (Tremors) 01/2015 - 10/2009
3	Alzheimer Disease (Alzheimer's Disease) 03/2012 - 07/2008
2	Ependymoma 05/2021 - 12/2017
2	Prolactinoma (Prolactinomas) 04/2021 - 10/2017
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2019 - 07/2017
2	Hemangiopericytoma 05/2018 - 01/2003
2	Hypoxia (Hypoxemia) 10/2017 - 04/2016
2	Mitochondrial Diseases (Mitochondrial Disease) 06/2015 - 12/2013
2	Pituitary Neoplasms (Pituitary Adenoma) 03/2014 - 03/2005
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2012 - 01/2012
2	Acoustic Neuroma (Acoustic Neurinoma) 01/2011 - 06/2009
2	Spinal Cord Injuries (Spinal Cord Injury) 10/2010 - 11/2009
2	Astrocytoma (Pilocytic Astrocytoma) 12/2008 - 08/2005
2	Oligodendroglioma 02/2008 - 07/2003
2	Subependymal Glioma (Subependymoma) 08/2005 - 01/2003
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022
1	Lung Neoplasms (Lung Cancer) 04/2022
1	Carcinogenesis 04/2021

Drug/Important Bio-Agent (IBA)

8	Levodopa (L Dopa)FDA LinkGeneric 05/2022 - 04/2008
8	Temozolomide (Temodar)FDA LinkGeneric 04/2020 - 07/2011
7	Pharmaceutical PreparationsIBA 04/2020 - 04/2012
6	Biological ProductsIBA 05/2018 - 12/2002
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2003
5	Cisplatin (Platino)FDA LinkGeneric 07/2011 - 11/2002
4	NestinIBA 01/2019 - 02/2004
4	Biomarkers (Surrogate Marker)IBA 01/2016 - 08/2005
4	NimustineIBA 07/2011 - 11/2002
3	Trifluoperazine (Stelazine)FDA LinkGeneric 04/2022 - 01/2017
3	Antipsychotic Agents (Antipsychotics)IBA 04/2022 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2014
3	Dopamine Agonists (Dopamine Agonist)IBA 04/2021 - 10/2017
3	Cytosine DeaminaseIBA 01/2020 - 10/2010
3	Flucytosine (Ancobon)FDA Link 01/2020 - 10/2010
3	AlbuminsIBA 01/2019 - 07/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016 - 12/2002
3	Fluorouracil (Carac)FDA LinkGeneric 03/2016 - 10/2010
2	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2021
2	Oxidopamine (6 Hydroxydopamine)IBA 12/2020 - 04/2012
2	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 04/2020 - 01/2017
2	MagnesiumIBA 03/2019 - 02/2018
2	Growth Hormone (Somatotropin)IBA 02/2019 - 03/2014
2	Insulin-Like Growth Factor I (IGF-1)IBA 02/2019 - 01/2018
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2019 - 01/2018
2	amsonic acid (DAS)IBA 01/2018 - 10/2017
2	ProlactinIBA 10/2017 - 03/2014
2	salicylhydroxamic acid (SHAM)IBA 10/2017 - 06/2007
2	CalciumIBA 01/2017 - 02/2010
2	Caffeine (No Doz)FDA LinkGeneric 01/2017 - 02/2010
2	CytokinesIBA 01/2017 - 06/2015
2	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 01/2017 - 02/2010
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 02/2016 - 09/2014
2	ProdrugsIBA 01/2016 - 10/2010
2	Fentanyl (Sublimaze)FDA LinkGeneric 01/2016 - 09/2014
2	EnzymesIBA 01/2016 - 10/2010
2	Propofol (Diprivan)FDA LinkGeneric 01/2016 - 09/2014
2	Indicators and Reagents (Reagents)IBA 11/2012 - 08/2006
2	Advanced Glycation End ProductsIBA 03/2012 - 01/2012
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2010 - 08/2005
2	Glial Fibrillary Acidic ProteinIBA 01/2008 - 02/2004
2	Matrix Metalloproteinases (MMPs)IBA 07/2006 - 12/2002
2	Tissue Inhibitor of Metalloproteinase-1IBA 07/2006 - 12/2002
1	platycodin DIBA 01/2022
1	TriterpenesIBA 01/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	Plant ExtractsIBA 01/2022
1	SaponinsIBA 01/2022
1	Protons (Proton)IBA 05/2021
1	EphrinsIBA 04/2021

Therapy/Procedure

36	Deep Brain Stimulation 05/2022 - 04/2008
23	Therapeutics 01/2022 - 11/2007
16	Radiotherapy 01/2020 - 03/2005
5	Electrodes (Electrode) 01/2017 - 12/2010
4	Transplantation 01/2020 - 06/2007
4	Drug Therapy (Chemotherapy) 07/2011 - 11/2002
4	Craniotomy 12/2008 - 02/2003
3	Combined Modality Therapy 01/2021 - 03/2013
3	Chemoradiotherapy 01/2019 - 02/2015
3	Adjuvant Radiotherapy 05/2018 - 11/2013
2	Activities of Daily Living (ADL) 11/2019 - 03/2011
2	Subcutaneous Injections 01/2019 - 09/2014
2	Aftercare (After-Treatment) 05/2012 - 04/2012
2	Particle Accelerators 02/2009 - 02/2003
2	Lasers (Laser) 01/2009 - 12/2002